Baker Bros. Advisors (GP) LLC
SEC CIK 1580575 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 10% | 367.8K | $1.61M | — | 2 | 2022-06-02 | 2025-11-10 |
| CELC | Celcuity Inc. | 10% | 703.9K | $9.57M | — | 1 | 2025-09-08 | 2025-09-08 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 1.95M | $36.94M | — | 2 | 2024-06-25 | 2025-08-18 |
| KYMR | Kymera Therapeutics, Inc. | Dir | 6.12M | $28.84M | — | 1 | 2025-06-30 | 2025-06-30 |
| ACAD | ACADIA PHARMACEUTICALS INC | Dir, 10% | 3.66M | — | — | 1 | 2025-05-29 | 2025-05-29 |
| ONC | BeOne Medicines Ltd. | Dir | 730.6K | — | $190.54M | 1 | 2025-02-28 | 2025-02-28 |
| BCYC | BICYCLE THERAPEUTICS PLC | Dir, 10% | 8.67M | $21.23M | — | 1 | 2024-12-13 | 2024-12-13 |
| INCY | Incyte | Dir, 10% | 28.18M | — | — | 4 | 2023-03-31 | 2024-06-28 |
| NGNE | Neurogene Inc. | Dir, 10% | 155.9K | — | — | 1 | 2023-10-05 | 2023-10-05 |
| KNSA | Kiniksa Pharmaceuticals International, plc | Dir | 109.0K | — | — | 1 | 2022-06-29 | 2022-06-29 |
| DBVT | DBV Technologies S.A. | Dir, 10% | 1.59M | — | — | 1 | 2022-06-13 | 2022-06-13 |
| KOD | Kodiak Sciences Inc. | Dir, 10% | 1.34M | $18.77M | — | 3 | 2021-08-11 | 2022-06-02 |
Most active insiders at TRDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PARMAR KUSH | Dir, 10% | — | $3.65M |
| 2 | MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| 3 | MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 4 | 5AM Ventures V, L.P. | 10% | — | $3.00M |
| 5 | Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| 6 | WENTWORTH KORY JAMES | CFO | — | $433.6K |
| 7 | Dowden Nathan J | Pres, COO | — | $425.7K |
| 8 | Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| 9 | BAKER FELIX | 10% | $261.8K | — |
| 10 | Zeiher Bernhardt G | Dir | $29.3K | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-11-12 | 2025-11-10+ | TRDA | Entrada Therapeutics, Inc. | Baker Bros. Advisors (GP) LLC | 10% | P - Purchase | $7.60 | +178.0K | 367.8K | +94% | +$1.35M |
| MI | 2025-09-10 | 2025-09-08 | CELC | Celcuity Inc. | Baker Bros. Advisors (GP) LLC | 10% | P - Purchase | $56.27 | +170.1K | 703.9K | +32% | +$9.57M |
| MI | 2025-08-20 | 2025-08-18+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Baker Bros. Advisors (GP) LLC | Dir | P - Purchase | $380.58 | +97.1K | 1.95M | +5% | +$36.94M |
| DMI | 2025-06-30 | 2025-06-30 | KYMR | Kymera Therapeutics, Inc. | Baker Bros. Advisors (GP) LLC | Dir | P - Purchase | $44.00 | +655.5K | 6.12M | +12% | +$28.84M |
| DMI | 2025-06-02 | 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Baker Bros. Advisors (GP) LLC | Dir, 10% | A - Grant | $0.00 | +32.4K | 3.66M | +0.9% | $0 |
| MI | 2025-02-28 | 2025-02-28 | ONC | BeOne Medicines Ltd. | Baker Bros. Advisors (GP) LLC | Dir | S - Sale | $260.00 | -732.8K | 730.6K | -50% | -$190.54M |
| MI | 2024-12-17 | 2024-12-13+ | BCYC | BICYCLE THERAPEUTICS PLC | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $14.29 | +1.49M | 8.67M | +21% | +$21.23M |
| MI | 2024-07-02 | 2024-06-28 | INCY | Incyte | Baker Bros. Advisors (GP) LLC | Dir, 10% | A - Grant | $0.00 | +1,074 | 28.18M | +0.0% | $0 |
| DMI | 2024-06-27 | 2024-06-25 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Baker Bros. Advisors (GP) LLC | Dir | A - Grant | $0.00 | +2,856 | 1.79M | +0.2% | $0 |
| DMI | 2024-06-14 | 2024-06-12 | INCY | Incyte | Baker Bros. Advisors (GP) LLC | Dir, 10% | A - Grant | $0.00 | +5,660 | 33.47M | +0.0% | $0 |
| DMI | 2024-06-14 | 2024-06-12 | INCY | Incyte | Baker Bros. Advisors (GP) LLC | Dir, 10% | D - Sale to Iss | $60.00 | -5.46M | 2.81M | -66% | -$327.55M |
| DMI | 2023-10-10 | 2023-10-05 | NGNE | Neurogene Inc. | Baker Bros. Advisors (GP) LLC | Dir, 10% | X - OptEx | — | +592.6K | 155.9K | New | — |
| MI | 2023-04-04 | 2023-03-31 | INCY | Incyte | Baker Bros. Advisors (GP) LLC | Dir, 10% | A - Grant | $0.00 | +858 | 33.44M | +0.0% | $0 |
| DMI | 2022-06-30 | 2022-06-29 | KNSA | Kiniksa Pharmaceuticals International, plc | Baker Bros. Advisors (GP) LLC | Dir | A - Grant | $0.00 | +20.0K | 109.0K | +22% | $0 |
| DMI | 2022-06-13 | 2022-06-13 | DBVT | DBV Technologies S.A. | Baker Bros. Advisors (GP) LLC | Dir, 10% | A - Grant | — | +11.88M | 1.59M | New | — |
| MI | 2022-06-06 | 2022-06-02+ | TRDA | Entrada Therapeutics, Inc. | Baker Bros. Advisors (GP) LLC | 10% | P - Purchase | $6.37 | +40.9K | 364.2K | +13% | +$260.7K |
| MI | 2022-06-06 | 2022-06-02+ | KOD | Kodiak Sciences Inc. | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $7.77 | +572.3K | 1.34M | +74% | +$4.45M |
| MI | 2021-09-09 | 2021-09-07 | KOD | Kodiak Sciences Inc. | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $93.31 | +57.5K | 13.27M | +0.4% | +$5.37M |
| MI | 2021-08-13 | 2021-08-11+ | KOD | Kodiak Sciences Inc. | Baker Bros. Advisors (GP) LLC | Dir, 10% | P - Purchase | $87.19 | +102.8K | 13.00M | +0.8% | +$8.96M |
Purchase Sale Sale after option exercise All abbreviations